In a new push to make popular weight loss drugs more affordable, the CEO of Novo Nordisk is set to face a grilling on Capitol Hill over the high cost of Ozempic, used to treat type 2 diabetes, and ...
WW International, owner of the WeightWatchers dieting business, has said chief executive Sima Sistani is stepping down with immediate effect as the group struggles with the growing popularity of ...